Logo image of USA

LIBERTY ALL STAR EQUITY FUND (USA) Stock Overview

USA - NYSE:USA - US5301581048

6.23 USD
-0.15 (-2.35%)
Last: 10/10/2025, 9:01:29 PM
6.2 USD
-0.03 (-0.48%)
After Hours: 10/10/2025, 9:01:29 PM
Fundamental Rating

2

Overall USA gets a fundamental rating of 2 out of 10. We evaluated USA against 0 industry peers in the Unkown industry. USA has a bad profitability rating. Also its financial health evaluation is rather negative. USA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

USA had positive earnings in the past year.
USA had positive earnings in 4 of the past 5 years.
In the past 5 years USA always reported negative operating cash flow.
USA Yearly Net Income VS EBIT VS OCF VS FCFUSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Industry RankSector Rank
ROA 19.36%
ROE 19.76%
ROIC 0.39%
ROA(3y)2.53%
ROA(5y)8.02%
ROE(3y)2.55%
ROE(5y)8.13%
ROIC(3y)0.43%
ROIC(5y)0.35%
USA Yearly ROA, ROE, ROICUSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

USA's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of USA has declined.
In the last couple of years the Gross Margin of USA has declined.
Industry RankSector Rank
OM 39.11%
PM (TTM) 1539.8%
GM 40.63%
OM growth 3Y24.22%
OM growth 5Y-2.17%
PM growth 3Y-21.32%
PM growth 5Y-10%
GM growth 3Y23.83%
GM growth 5Y-1.54%
USA Yearly Profit, Operating, Gross MarginsUSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, USA has more shares outstanding
The number of shares outstanding for USA has been increased compared to 5 years ago.
The debt/assets ratio for USA is higher compared to a year ago.
USA Yearly Shares OutstandingUSA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
USA Yearly Total Debt VS Total AssetsUSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 27.16 indicates that USA is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.00 indicates that USA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 27.16
ROIC/WACCN/A
WACCN/A
USA Yearly LT Debt VS Equity VS FCFUSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

USA has a Current Ratio of 0.85. This is a bad value and indicates that USA is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.85 indicates that USA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85
USA Yearly Current Assets VS Current LiabilitesUSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

2

3. Growth

3.1 Past

USA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 190.37%, which is quite impressive.
USA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.67% yearly.
Looking at the last year, USA shows a small growth in Revenue. The Revenue has grown by 4.69% in the last year.
The Revenue has been growing slightly by 4.80% on average over the past years.
EPS 1Y (TTM)190.37%
EPS 3Y-15.72%
EPS 5Y-11.67%
EPS Q2Q%324.17%
Revenue 1Y (TTM)4.69%
Revenue growth 3Y11.89%
Revenue growth 5Y4.8%
Sales Q2Q%7.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
USA Yearly Revenue VS EstimatesUSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.33 indicates a rather cheap valuation of USA.
USA is valuated cheaply when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.33
Fwd PE N/A
USA Price Earnings VS Forward Price EarningsUSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USA Per share dataUSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

USA has a Yearly Dividend Yield of 10.91%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.43, USA pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.91%

5.2 History

USA has been paying a dividend for at least 10 years, so it has a reliable track record.
USA has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
USA Yearly Dividends per shareUSA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
USA Yearly Income VS Free CF VS DividendUSA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

More info and screens

LIBERTY ALL STAR EQUITY FUND

NYSE:USA (10/10/2025, 9:01:29 PM)

After market: 6.2 -0.03 (-0.48%)

6.23

-0.15 (-2.35%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-27 2025-08-27
Earnings (Next)11-20 2025-11-20
Inst Owners11.79%
Inst Owner Change-0.06%
Ins Owners0.09%
Ins Owner Change1.18%
Market Cap1.84B
Analysts0
Price TargetN/A
Short Float %0.03%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 10.91%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date07-18 2025-07-18 (0.18)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.33
Fwd PE N/A
P/S 71.3
P/FCF N/A
P/OCF N/A
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)1.44
EY23.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.09
BVpS6.81
TBVpS6.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 19.36%
ROE 19.76%
ROCE 0.5%
ROIC 0.39%
ROICexc 0.39%
ROICexgc 0.39%
OM 39.11%
PM (TTM) 1539.8%
GM 40.63%
FCFM N/A
ROA(3y)2.53%
ROA(5y)8.02%
ROE(3y)2.55%
ROE(5y)8.13%
ROIC(3y)0.43%
ROIC(5y)0.35%
ROICexc(3y)0.43%
ROICexc(5y)0.35%
ROICexgc(3y)0.43%
ROICexgc(5y)0.35%
ROCE(3y)0.55%
ROCE(5y)0.44%
ROICexcg growth 3Y40.51%
ROICexcg growth 5Y-4.15%
ROICexc growth 3Y40.51%
ROICexc growth 5Y-4.15%
OM growth 3Y24.22%
OM growth 5Y-2.17%
PM growth 3Y-21.32%
PM growth 5Y-10%
GM growth 3Y23.83%
GM growth 5Y-1.54%
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z 27.16
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)190.37%
EPS 3Y-15.72%
EPS 5Y-11.67%
EPS Q2Q%324.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.69%
Revenue growth 3Y11.89%
Revenue growth 5Y4.8%
Sales Q2Q%7.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.7%
EBIT growth 3Y38.98%
EBIT growth 5Y2.53%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A